Sort
50,496 grants matching “lung cancer”
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,023,709Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,023,709Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Comparative Biomedical Scientist Training Program
$1,023,705Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2023 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center
$1,023,664Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA
Clinical Validation Center for Lung Cancer Early Detection
$1,023,059Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
XoLacta: An Adjuvant Therapy for treatment of Radiation Side effects during HER2-Positive Breast Cancer Treatment
$1,022,907Spencer Reid Marsh · Tiny Cargo Company, The · R44 · FY2025 · CA
A Prospective Study of Alaska Natives &American Indians
$1,022,816Alaska Native Tribal Health Consortium · R01 · FY2002 · CA
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
$1,022,540Eric L Grogan · Vanderbilt University Medical Center · U01 · FY2020 · CA
Molecular Analysis Of Cell Cycle Control During Carcinogenesis
$1,022,497Richard Paules · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial
$1,021,979Kathryn H. Schmitz · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Translational Research Center in Lung Cancer Disparities (TRACER)
$1,021,757Robert Andrew Winn · Virginia Commonwealth University · P20 · FY2023 · CA
General Clinical Research Center
$1,021,752Richard D Krugman · University Of Colorado Denver · M01 · FY2008 · RR
Comparative Biomedical Scientist Training Program
$1,021,229Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2014 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,021,151Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,021,151Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,835Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2018 · CA
Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial
$1,020,434William Lake · Information Management Services, Inc. · N02 · FY2010 · CA
Preparation of sequencing libraries for multi-analyte analysis of RNAs
$1,020,220Sergei A Kazakov · Realseq Biosciences, Inc. · R44 · FY2025 · HG
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,143Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2017 · CA
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$1,019,945Robert A Salata · Case Western Reserve University · U54 · FY2022 · CA
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
$1,019,623Leopoldo Nicolas Segal · New York University School Of Medicine · U2C · FY2025 · CA
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer
$1,019,583Anita Bellail · Hb Therapeutics, Inc. · R44 · FY2022 · CA
Leadership, Planning and Evaluation
$1,019,114Caryn Lerman · University Of Southern California · P30 · FY2022 · CA
Improved Treatment of Colorectal Cancer with CF10
$1,018,545William H Gmeiner · Deep Creek Pharma, Llc · R42 · FY2024 · CA
Epidemiology of Putative Causal Variants in the Multiethnic Cohort
$1,018,523Loic Le Marchand · University Of Hawaii At Manoa · U01 · FY2009 · HG